Numerai’s Opko Health OPK Stock Holding History

Numerai’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-133,187	Closed	-$221K	–	583
2025 Q1	$221K	Sell	133,187 -6,568	-5%	-$10.8K	0.04%	444
2024 Q4	$205K	Buy	+139,755	New	+$214K	0.06%	357
2023 Q3	–	Sell	-1,192,116	Closed	-$2.59M	–	249
2023 Q2	$2.59M	Sell	1,192,116 -1,016,179	-46%	-$1.59M	0.53%	62
2023 Q1	$3.22M	Buy	2,208,295 +317,568	+17%	+$409K	1.08%	21
2022 Q4	$2.36M	Buy	+1,890,727	New	+$2.98M	1.61%	18

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Numerai's OPK Position: Q2 2025 in Review

Numerai sold out of Opko Health (OPK) in Q2 2025, closing a stake of 133,187 shares — an estimated $221K sold.

Numerai first reported a position in OPK in Q4 2022 and held it in 5 quarters. The position peaked at $3.22M in Q1 2023. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

Numerai reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
Numerai sold 133,187 Opko Health shares in Q2 2025, an estimated $221K.
Numerai first reported a position in Opko Health in Q4 2022 and held it in 5 quarters.
Numerai's Opko Health position peaked at $3.22M in Q1 2023.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Numerai's 13F filing for Q2 2025, filed 14 Aug 2025.